Eschbach W, Glathe H, NOBEL B, Bergmann U
Arch Geschwulstforsch. 1974;44(3):246-59.
Using HVH 2 antisera of rabbit (titre 1:256, dilution 1:10), antologous serum of cervix carcinoma patients (dilution 1:1 to 1:5) and allogenic serum of cervix carcinoma patients without HVH 2 antibodies (dilution 1:1 to 1:5), tumour material obtained from various cancerization stages of cervix carcinoma in 50 cases was incubated following trypsination to single cells with fluoresceine isothiocyanate labelled anti-human globulin and anti-rabbit globulin. Apart from HVH antigens significantly differing in quantity from one stage to the other as detected by immune fluorescence methods, a perinuclear distinct antigen, unrelated to HVH antigens, has also been demonstrated. The last mentioned one might be a specific tumour antigen or an embryonic antigen. The occurrence of an indirectly or directly HVH 2 inducing antigen is considered less probable.
采用兔抗H VH 2血清(效价1:256,稀释度1:10)、宫颈癌患者自身血清(稀释度1:1至1:5)以及无H VH 2抗体的宫颈癌患者同种异体血清(稀释度1:1至1:5),将50例宫颈癌不同癌变阶段获取的肿瘤材料经胰蛋白酶消化成单细胞后,与异硫氰酸荧光素标记的抗人球蛋白和抗兔球蛋白一起孵育。通过免疫荧光法检测发现,除了不同阶段H VH抗原数量存在显著差异外,还证实了一种与H VH抗原无关的核周特异性抗原。后一种抗原可能是一种特异性肿瘤抗原或胚胎抗原。而诱导间接或直接产生H VH 2的抗原出现的可能性较小。